Novartis may spin off agribusiness


16 September 1999


Novartis may spin off agribusiness


NOVARTIS, the Swiss life sciences group, could spin off or merge its agribusiness division involved in the development of genetically modified crops.

Heinz Imhof, chief executive of the agribusiness arm, said the group was considering options for its second biggest business where profits are under pressure.

He emphasised that no decision had been taken as yet on the agribusiness arm which is thought to be worth about $15bn.

See more